Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T07:51:23.034Z Has data issue: false hasContentIssue false
  • English
  • Français

Combinación de nefazodona y midazolam durante terapia electroconvulsiva

Published online by Cambridge University Press:  12 May 2020

A. Conca ,
Z. Al-Dubai ,
P. König  and
W. Beraus
A. Conca
Affiliation:
Departamento de Psiquiatría I, Hospital Regional Rankweil, Rankweil, Austria
Z. Al-Dubai
Affiliation:
Departamento de Psiquiatría I, Hospital Regional Rankweil, Rankweil, Austria
P. König
Affiliation:
Departamento de Psiquiatría I, Hospital Regional Rankweil, Rankweil, Austria
W. Beraus
Affiliation:
Departamento de Psiquiatría I, Hospital Regional Rankweil, Rankweil, Austria
Get access

Resumen

Comunicamos el caso de un paciente que sufría distimia. Fue sometido a un tratamiento de ECT con éxito y fue medicado con nefazodona y midazolam. Comparando el EEG y la duración de la crisis motora en los periodos con y sin midazolam, no se registraron diferencias significativas, pero las dosis de tiopental y de succinilcolina se tuvieron que aumentar de manera notable después de la interrupción del midazolam (P < 0,05; ANOVA). Este caso indica una interacción farmacodinámica sustancial entre nefazodona, midazolam, tiopental y succinilcolina.

Keywords

TECmidazolamnefazodona
Type
Informe Clínico
Information
European Psychiatry (Ed. Española) , Volume 7 , Issue 5 , June 2000 , pp. 314 - 317
Copyright
Copyright © European Psychiatric Association 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

American Psychiatric Association. The practice of ECT: recommendations for treatment, training, and privileging. Task force report on ECT. Washington, DC: American Psychiatric Press; 1990.Google Scholar
Coffey, CELucke, JWeiner, RDKrystal, ADAque, M.Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry 1995;37:713–20.CrossRefGoogle ScholarPubMed
Gassy, JERay, JM.A survey of ECT in a general hospital psychiatric unit. Aust NZ J Psychiatry 1990;24:385–90.CrossRefGoogle Scholar
Greenberg, RMPettinati, HM.Benzodiazepine and electroconvulsive therapy. Convulsive Ther 1993;9:262–73.Google ScholarPubMed
Kellner, CHBourgon, LN.Combining ECT and antide-pressants: time to reassess. J Ect 1998;14:65–7.CrossRefGoogle Scholar
Linder, MWRussell, APrough, AValdes, R.Jr. Pharmacogenetics: a laboratory tool for optimizing thera-peutic efficiency. Clin Chem 1997;43:254–66.CrossRefGoogle Scholar
Nemeroff, CBdeVane, CLPollock, BG.Newer antide-pressants and the cytochrome P450 System. Am J Psychiatry 1996;28:241–7.Google Scholar
Pritchett, JTBernstein, JHKellner, CH.Combinded ECT and antidepressant drug therapy. Convulsive Ther 1993;9:256–61.Google Scholar
Sackeim, HA.Optimizing unilateral electroconvulsive therapy. Convulsive Ther 1991;7:201–12.Google ScholarPubMed
Selvin, BL.Electroconvulsive therapy-1987. Anesthesiology 1987;67:367–85.CrossRefGoogle ScholarPubMed